DM-calendar app as a diabetes self-management education on adult type 2 diabetes mellitus: a randomized controlled trial
| Main Authors: | Kusnanto, -, Komang Agus Jerry Widyanata, -, Suprajitno, -, Hidayat Arifin, - |
|---|---|
| Format: | Article PeerReviewed Book |
| Bahasa: | eng |
| Terbitan: |
Springer International Publising
, 2019
|
| Subjects: | |
| Online Access: |
http://repository.unair.ac.id/92378/1/32.%20DM-Calendar.pdf http://repository.unair.ac.id/92378/2/DM%20calendar%20app%20as%2010122019.pdf http://repository.unair.ac.id/92378/3/32.%20DM-Calendar%20turnitin.pdf http://repository.unair.ac.id/92378/ https://www.springermedizin.de/dm-calendar-app-as-a-diabetes-self-management-education-on-adult/17406090 |
Daftar Isi:
- Purpose Era Disruption 4.0 demands development in the management of Diabetes Mellitus (DM) by using application-based intervention that can facilitate nursing intervention. The aim was to evaluate the effect of diabetes mellitus calendar app as a Diabetes Self-Management Education (DSME) program on self-efficacy, HbA1c levels, lipid profile, and insulin in adult type 2 diabetes mellitus (T2DM). Methods It was randomized experimental design — simple random sampling used with a total sample of 30 respondents. The instruments used diabetes management self-efficacy scales and standard of operational procedure blood sampling. The statistical tests used were a Paired t-test, Wilcoxon, and an Independent t-test. Results DSME with an Android-based DM calendar affected self-efficacy (p < 0.001), HbA1c levels (p = 0.005), cholesterol(p = 0.009), triglyceride (p = 0.000), HDL-c (p = 0.048), LDL-c (p = 0.010), and insulin (p = 0.000) compared with the control group. Education with these electronic media has increased the perception of self-efficacy and improved the behavior of good self-management that can be seen from changes in controlled HbA1c level, lipid profile and insulin. Conclusion The results of this study can be used as a reference for providing educational experimental in patients with Type 2 Diabetes Mellitus (T2DM).